Sagemedic
1 known investors
SAGE Medic offers the SAGE Oncotest, a functional tumor profiling assay that analyzes a patient's fresh cancer tissue against a curated list of FDA-approved drugs to indicate resistance or responsiveness, delivering laboratory insights within 7-10 days. The test is designed to help oncologists and cancer patients make more individualized treatment decisions.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Sagemedic do?
- SAGE Medic offers the SAGE Oncotest, a functional tumor profiling assay that analyzes a patient's fresh cancer tissue against a curated list of FDA-approved drugs to indicate resistance or responsiveness, delivering laboratory insights within 7-10 days. The test is designed to help oncologists and cancer patients make more individualized treatment decisions.
- Who are Sagemedic's investors?
- Sagemedic's investors include Keiretsu Forum.